Originator Organization Egle Therapeutics SASStartup |
Active Organization Egle Therapeutics SASStartup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | FR | Egle Therapeutics SASStartup | 08 Jun 2023 |